News
-
Xceleron And Crystal Pharmatech Announce Partnership To Improve Early Clinical Development Utilizing Absolute Bioavailability Trials And Solid-State Solutions
1/22/2013
Xceleron, a U.S.-based leader in the application of ultra-sensitive analytical technology to novel clinical designs, has announced a partnership that will offer drug developers early bioavailability data that will lead to optimized solid-state forms and formulations. The partnership with Crystal Pharmatech, a China-based, technology-driven, solid-state research CRO, will enable sponsors to make faster decisions in the early stages of development.
-
Xcelience Expands Clinical Trial Supplies Manufacturing And Packaging
9/7/2012
Xcelience, a leader in early drug development, has expanded clinical trial supplies manufacturing and packaging capabilities to include four new pieces of equipment and a new fully-automated packaging line.
This website uses cookies to ensure you get the best experience on our website. Learn more